AFF3 upregulation mediates tamoxifen resistance in breast cancers

BACKGROUND: Although tamoxifen is a highly effective drug for treating estrogen receptor–positive (ER(+)) breast cancer, nearly all patients with metastasis with initially responsive tumors eventually relapse, and die from acquired drug resistance. Unfortunately, few molecular mediators of tamoxifen...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Exp Clin Cancer Res
Main Authors: Shi, Yawei, Zhao, Yang, Zhang, Yunjian, AiErken, NiJiati, Shao, Nan, Ye, Runyi, Lin, Ying, Wang, Shenming
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2018
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6192118/
https://ncbi.nlm.nih.gov/pubmed/30326937
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13046-018-0928-7
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados